Generating AI analysis...
AI Earnings Analysis
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue | $30.87M | $35.89M | -13.99% |
Operating Income | $-230.8M | $-253.05M | +8.79% |
Net Income | $-101.25M | $-146.97M | +31.11% |
EPS (Basic) | $-2.08 | $-2.64 | +21.21% |
EPS (Diluted) | $-2.08 | $-2.64 | +21.21% |
R&D Expense | $205.46M | $226.05M | -9.11% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Total Assets | $898.89M | $1.19B | -24.56% |
Current Assets | $495.94M | $757.21M | -34.50% |
Total Liabilities | $183.64M | $220.47M | -16.71% |
Current Liabilities | $95.5M | $105.09M | -9.13% |
Stockholders' Equity | $715.25M | $971.06M | -26.34% |
Cash & Equivalents | $156.17M | $130.85M | +19.35% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Cash Flow | $-248.55M | $-178.85M | -38.97% |
Investing Cash Flow | $201.24M | $-18.29M | +1200.32% |
Financing Cash Flow | $14.65M | $101.24M | -85.53% |
D&A | $4.97M | $5.11M | -2.72% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Margin | -747.6% | -705.0% | -42.59% |
Net Margin | -328.0% | — | — |
ROE | -14.2% | — | — |
ROA | -11.3% | — | — |
Current Ratio | $5.193 | — | — |
Debt to Equity | $0.257 | — | — |
Other companies in Biotechnology